VidaTalk

Разработчик: Vidatak

Описание

VidaTalk™ is an interactive, multilingual communication tool for non-verbal patients, also serving facilities where patients and providers may speak different languages. VidaTalk is specifically designed and tested for the hospital environment with funding support from the National Institutes of Health, National Institute of Nursing Research NR014087. The most common phrases used by hospitalized patients can be selected with a single touch. Patients may also type personalized messages and draw with their finger which allows for quick, easy and customizable communication. Words and phrases specific to their needs are expressed through recorded audio across gender and language, giving every patient a voice.
This version of VidaTalk includes English and bilingual communication with both verbal and written translation for 40 languages: Amharic, Arabic, Armenian, Bosnian, Burmese, Cantonese, Chinese, Creole, Czech, Dari, Dutch, English, Farsi, French, German, Greek, Hindi, Hmong, Indonesian, Italian, Japanese, Khmer, Korean, Lithuanian, Marshallese, Nepalese, Pashto, Polish, Portuguese, Punjabi, Russian, Somali, Spanish, Swedish, Tagalog, Thai, Tigrinya, Turkish, Ukrainian, and Vietnamese.
Speech solutions for long-term or chronic communication disabilities often fail to meet the unique needs of the healthcare environment and leave non-verbal patients unable to actively participate with their care. VidaTalk is an essential component of any critical care and equity, diversity and inclusion communication program. If you, a family member, or loved-one is hospitalized and suffers from speech or language barrier, be sure to download VidaTalk today!
Subscriptions
Monthly and yearly subscriptions for unlimited use are available for purchase. Volume tiered, hospital-wide and enterprise pricing available.
More information on VidaTalk can be found at vidatak.com/support.
Скрыть Показать больше...

Встроенные покупки

Yearly - All Languages
USD 189.99
Monthly - All Languages
USD 49.99

Скриншоты

VidaTalk Частые Вопросы

  • Приложение VidaTalk бесплатное?

    Да, VidaTalk можно скачать бесплатно, однако в приложении есть встроенные покупки или подписки.

  • Является ли VidaTalk фейковым или мошенническим?

    Недостаточно отзывов для надежной оценки. Приложению нужно больше отзывов пользователей.

    Спасибо за ваш голос

  • Сколько стоит VidaTalk?

    VidaTalk имеет несколько покупок/подписок внутри приложения, средняя цена покупки составляет USD 119.99.

  • Сколько зарабатывает VidaTalk?

    Чтобы получить оценку дохода приложения VidaTalk и другие данные AppStore, вы можете зарегистрироваться на платформе мобильной аналитики AppTail.

Оценки пользователей
Приложение еще не оценено в Аргентина.
История оценок

VidaTalk Отзывы Пользователей

Нет отзывов в Аргентина
Приложение пока не имеет отзывов в Аргентина.

Оценки

История позиций в топах
История рейтингов пока не доступна
Позиции в категории
Приложение еще не было в топах

VidaTalk Конкуренты

Name
SmallTalk Letters,Number,Color
Aphasia Speech Video Exercises
SmallTalk Common Phrases
Aphasia Speech Video Exercises
SmallTalk Intensive Care
Aphasia Communication App
SmallTalk Daily Activities
Aphasia Communication App
ASD Bestie Type to Speak
Aphasia Afasia Speech Therapy
YoDoc
Patient Communication tool
Patient Communicator
Communicare ICU
Patient Communicator
AAC Bestie Autism Communicator
Communication Boards, SLP Core
ElineSpeaks - AAC speech app
Speech generating device (SGD)

VidaTalk Установки

30дн.

VidaTalk Доход

30дн.

VidaTalk Доходы и Загрузки

Получите ценные инсайты о производительности VidaTalk с помощью нашей аналитики.
Зарегистрируйтесь сейчас, чтобы получить доступ к статистика загрузок и доходов и многому другому.
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.